|
"liang ph"的相關文件
顯示項目 21-29 / 29 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
|
Chen, CN; Lin, CPC; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH; Hsu, JTA |
| 國家衛生研究院 |
2004-12-10 |
One site mutation disrupts dimer formation in human DPP-IV proteins
|
Chien, CH; Huang, LH; Chou, CY; Chen, YS; Han, YS; Chang, GG; Liang, PH; Chen, X |
| 國家衛生研究院 |
2004-09-10 |
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV
|
Hsu, JTA; Kuo, CJ; Hsieh, HP; Wang, YC; Huang, KK; Lin, CPC; Huang, PF; Chen, X; Liang, PH |
| 國家衛生研究院 |
2004-07-23 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate [Erratum: Biochemical and Biophysical Research Communications. 2004 Jun;318(4):862-867.]
|
Kuo, CJ; Chi, YH; Hsu, JTA; Liang, PH |
| 國立臺灣大學 |
2004-07 |
Small molecules targeting severe acute respiratory syndrome human coronavirus.
|
Wu, CY; Jan, JT; Ma, SH; Kuo, CJ; Juan, HF; Cheng, YS; Hsu, HH; Huang, HC; Wu, D; Brik, A; Liang, FS; Liu, RS; Fang, JM; Chen, ST; Liang, PH; Wong, CH |
| 國家衛生研究院 |
2004-06-11 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
|
Kuo, CJ; Chi, YH; Hsu, JTA; Liang, PH |
| 國家衛生研究院 |
2004-05 |
Purification and characterization of human prolyl dipeptidase DPPS in Sf9 insect cells
|
Chen, YS; Chien, CH; Goparaju, CM; Hsu, JTA; Liang, PH; Chen, X |
| 國立臺灣大學 |
2004-03 |
DiGeorge syndrome with truncus arteriosus: report of one case.
|
Liang, PH; Chen, MR; Shyur, SD; Lee, YJ; Lin, SP; Yu, MT; Chiu, IS; Chen, SJ |
| 國立臺灣大學 |
2004 |
One site mutation disrupts dimer formation in human DPP-IV proteins
|
Chien CH; Huang LH; Chou CY; Chen YS; Han YS; Chang GG; Liang PH; Chen X |
顯示項目 21-29 / 29 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
|
